Skip to content

Clinical trials

Polymyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polymyositis Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20052
20062
20071
20082
20103
20115
20121
20133
20144
20152
20161
20173
20181
20191
20203
20215
20222
20237
20242
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting16
Unknown status6
Terminated5
Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)5
Karolinska Institutet4
National Institute of Environmental Health Sciences (NIEHS)4
Amgen3
AstraZeneca2
Karolinska University Hospital2
Kezar Life Sciences, Inc.2
Northern Care Alliance NHS Foundation Trust2
Novartis Pharmaceuticals2
Paean Biotechnology Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polymyositis73
Dermatomyositis67
Myositis38
Lupus Erythematosus, Systemic11
Myositis, Inclusion Body11
Arthritis, Rheumatoid9
Scleroderma, Diffuse7
Scleroderma, Systemic7
Autoimmune Diseases5
Connective Tissue Diseases5

Trials

Showing 51 to 73 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.